"Key Drivers Impacting Executive Summary Dual GIP/ GLP-1 Receptor Agonists Obesity Drugs Market Size and Share The global dual GIP/ GLP-1 receptor agonists obesity drugs market size was valued at USD 4.75 billion in 2024 and is expected to reach USD 17.71 billion by 2032, at a CAGR of 17.85% during the forecast period Analysis and discussion of important...

Market Overview: Precision in Drug Development The global bioanalytical testing services market was valued at USD 4.87 billion in 2024 and is projected to register a CAGR of 9.70% from 2025 to 2034 The market’s high growth trajectory is fundamentally linked to the revolutionary shifts occurring in the pharmaceutical and biotechnology industries. Specifically, the pivot towards...